Oruka Therapeutics (ORKA) Non-cash Items (2011 - 2026)
Oruka Therapeutics' quarterly Non-cash Items came in at $161.0 million in Q1 2026, up 3322.34% year-on-year from $4.7 million in Q1 2025, and up 130.09% quarter-over-quarter from $70.0 million in Q4 2025.
Oruka Therapeutics has reported Non-cash Items for 16 years, with the latest figure at $161.0 million in Q1 2026.
- For the quarter ending Q1 2026, Non-cash Items rose 3322.34% year-over-year to $161.0 million; the trailing twelve-month figure through Mar 2026 stood at $161.0 million (up 3322.34% YoY), and the FY2025 full-year result was $972898.0, down 93.71% from the prior year.
- Non-cash Items for Q1 2026 stood at $161.0 million, up from $70.0 million in the prior quarter.
- The five-year high for Non-cash Items was $161.0 million in Q1 2026, with the low at $18000.0 in Q4 2022.
- Average Non-cash Items over 5 years is $15.1 million, with a median of $470276.0 recorded in 2025.
- Year-over-year, Non-cash Items sank 99.05% in 2022 and jumped 4115.26% in 2024.
- Tracing ORKA's Non-cash Items over 5 years: stood at $18000.0 in 2022, then soared by 1938.89% to $367000.0 in 2023, then jumped by 4115.26% to $15.5 million in 2024, then surged by 352.27% to $70.0 million in 2025, then surged by 130.09% to $161.0 million in 2026.
- The last three Non-cash Items figures came in at $161.0 million (Q1 2026), $70.0 million (Q4 2025), and $730123.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 160.99 Mn |
| Mar 31, 2026 | 160.99 Mn |
| Dec 31, 2025 | 69.97 Mn |
| Dec 31, 2025 | 69.97 Mn |
| Sep 30, 2025 | 730,123.00 |
| Sep 30, 2025 | 730,123.00 |
| Jun 30, 2025 | 470,276.00 |
| Jun 30, 2025 | 470,276.00 |
| Mar 31, 2025 | 4.70 Mn |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | 15.47 Mn |
| Dec 31, 2024 | 15.47 Mn |
| Sep 30, 2024 | 680,000.00 |
| Sep 30, 2024 | 680,000.00 |
| Jun 30, 2024 | 506,540.00 |
| Jun 30, 2024 | 506,540.00 |
| Mar 31, 2024 | 502,517.00 |
| Mar 31, 2024 | 502,517.00 |
| Dec 31, 2023 | 367,000.00 |
| Dec 31, 2023 | 367,000.00 |
| Sep 30, 2023 | 413,834.00 |
| Sep 30, 2023 | 413,834.00 |
| Jun 30, 2023 | 367,516.00 |
| Jun 30, 2023 | 367,516.00 |
| Mar 31, 2023 | 363,281.00 |
| Mar 31, 2023 | 363,281.00 |
| Dec 31, 2022 | 18,000.00 |
| Dec 31, 2022 | 18,000.00 |
| Sep 30, 2022 | 335,467.00 |
| Sep 30, 2022 | 335,467.00 |
| Jun 30, 2022 | 288,179.00 |
| Jun 30, 2022 | 288,179.00 |
| Mar 31, 2022 | 215,387.00 |
| Mar 31, 2022 | 215,387.00 |
| Dec 31, 2021 | 1.90 Mn |
| Dec 31, 2021 | 1.90 Mn |
| Sep 30, 2021 | 125,951.00 |
| Sep 30, 2021 | 125,951.00 |
| Jun 30, 2021 | 100,180.00 |
| Jun 30, 2021 | 100,180.00 |
| Mar 31, 2021 | 66,125.00 |
| Mar 31, 2021 | 66,125.00 |
| Dec 31, 2020 | 1.60 Mn |
| Dec 31, 2020 | 1.60 Mn |
| Sep 30, 2020 | 31,013.00 |
| Sep 30, 2020 | 31,013.00 |
| Jun 30, 2020 | 30,684.00 |
| Jun 30, 2020 | 30,684.00 |
| Mar 31, 2020 | 30,526.00 |
| Mar 31, 2020 | 30,526.00 |
| Dec 31, 2019 | 30,074.00 |
| Dec 31, 2019 | 30,074.00 |
| Sep 30, 2019 | 30,644.00 |
| Sep 30, 2019 | 30,644.00 |
| Jun 30, 2019 | 29,618.00 |
| Jun 30, 2019 | 29,618.00 |
| Mar 31, 2019 | 28,487.00 |
| Mar 31, 2019 | 28,487.00 |
| Dec 31, 2018 | 486,420.00 |
| Dec 31, 2018 | 486,420.00 |
| Sep 30, 2018 | 447,317.00 |
| Sep 30, 2018 | 447,317.00 |
| Jun 30, 2018 | 428,387.00 |
| Jun 30, 2018 | 428,387.00 |
| Mar 31, 2018 | 393,106.00 |
| Mar 31, 2018 | 393,106.00 |
| Dec 31, 2017 | 447,000.00 |
| Dec 31, 2017 | 447,000.00 |
| Sep 30, 2017 | 294,215.00 |
| Sep 30, 2017 | 294,215.00 |
| Jun 30, 2017 | 251,748.00 |
| Jun 30, 2017 | 251,748.00 |
| Mar 31, 2017 | 209,658.00 |
| Mar 31, 2017 | 209,658.00 |
| Dec 31, 2016 | 25,000.00 |
| Dec 31, 2016 | 25,000.00 |
| Sep 30, 2016 | 159,887.00 |
| Sep 30, 2016 | 159,887.00 |
| Jun 30, 2016 | 131,876.00 |
| Jun 30, 2016 | 131,876.00 |
| Mar 31, 2016 | 114,852.00 |
| Mar 31, 2016 | 114,852.00 |
| Dec 31, 2015 | 114,198.00 |
| Dec 31, 2015 | 114,198.00 |
| Sep 30, 2015 | 105,678.00 |
| Sep 30, 2015 | 105,678.00 |
| Jun 30, 2015 | 660,493.00 |
| Jun 30, 2015 | 660,493.00 |
| Mar 31, 2015 | 576,567.00 |
| Mar 31, 2015 | 576,567.00 |
| Dec 31, 2014 | 633,000.00 |
| Dec 31, 2014 | 633,000.00 |
| Sep 30, 2014 | 416,822.00 |
| Sep 30, 2014 | 416,822.00 |
| Jun 30, 2014 | 342,333.00 |
| Jun 30, 2014 | 342,333.00 |
| Mar 31, 2014 | 266,655.00 |
| Mar 31, 2014 | 266,655.00 |
| Dec 31, 2013 | 194,550.00 |
| Dec 31, 2013 | 194,550.00 |
| Sep 30, 2013 | 115,435.00 |
| Sep 30, 2013 | 115,435.00 |
| Jun 30, 2013 | 126,197.00 |
| Jun 30, 2013 | 126,197.00 |
| Mar 31, 2013 | 123,408.00 |
| Mar 31, 2013 | 123,408.00 |
| Dec 31, 2012 | 125,666.00 |
| Dec 31, 2012 | 125,666.00 |
| Sep 30, 2012 | 723,337.00 |
| Sep 30, 2012 | 723,337.00 |
| Jun 30, 2012 | 461,000.00 |
| Jun 30, 2012 | 461,000.00 |
| Dec 31, 2011 | 102,691.00 |
| Dec 31, 2011 | 102,691.00 |